Digbi Health Expands its Multi-Condition Care Platform to Enhance Efficacy and Adherence to GLP-1 Drugs

PALO ALTO, Calif., Jan. 17, 2025 (GLOBE NEWSWIRE) -- Digbi Health, a pioneer in Precision Biology, is advancing obesity management with groundbreaking enhancements to GLP-Compass (™), its industry-leading obesity test. Digbi Health is introducing innovative components to personalize nutritional and pharmacotherapy support to ensure everyone receives the right care based on their biology and lifestyle.

Understanding the Different Causes of Obesity to Personalize Treatment

The causes of obesity vary widely among individuals based on their genetics, gut microbiome, glucose metabolism and lifestyle. For some, obesity is primarily driven by insulin-related metabolic issues. For others, it stems from gut-brain axis dysfunction, influencing cravings and hunger regulation. Additionally, some individuals may experience a combination of gut-brain issues affecting satiety, mental health factors, and lifestyle constraints. By isolating these different phenotypes, Digbi Health can tailor treatment approaches more precisely, leading to 3X better weight outcomes than traditional one-size-fits-all interventions.

Click here for more…..